Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Main subject
Language
Publication year range
1.
Preprint in English | bioRxiv | ID: ppbiorxiv-436639

ABSTRACT

The current global COVID-19 pandemic led to an unprecedented effort to develop effective vaccines against SARS-CoV-2. mRNA vaccines were developed very rapidly during the last year, and became the leading immunization platform against the virus, with highly promising phase-3 results and remarkable efficacy data. Since most animal models are not susceptible to SARS CoV-2 infection, pre-clinical studies are often limited to infection-prone animals such as hamsters and non-human primates. In these animal models, SARS-CoV-2 infection results in viral replication and a mild disease disease. Therefore, the protective efficacy of the vaccine in these animals is commonly evaluated by its ability to elicit immunologic responses, diminish viral replication and prevent weight loss. Our lab recently reported the design of a SARS-CoV-2 human Fc-conjugated receptor-binding domain (RBD-hFc) mRNA vaccine delivered via lipid nanoparticles (LNPs). These experiments demonstrated the development of a robust and specific immunologic response in RBD-hFc mRNA-vaccinated BALB/c mice. In the current study, we evaluated the protective effect of this RBD-hFc mRNA vaccine by employing the K18-hACE2 mouse model. We report that administration of RBD-hFc mRNA vaccine to K18-hACE2 mice led to a robust humoral response comprised of both binding and neutralizing antibodies. In accordance with the recorded immunologic immune response, 70% of vaccinated mice were protected against a lethal dose (3000 plaque forming units) of SARS-CoV-2, while all control animals succumbed to infection. To the best of our knowledge, this is the first non-replicating mRNA vaccine study reporting protection of K18-hACE2 against a lethal SARS-CoV-2 infection.

2.
J Phys Chem B ; 117(9): 2820-6, 2013 Mar 07.
Article in English | MEDLINE | ID: mdl-23394578

ABSTRACT

We report on the formation of unprecedented "leek"-shaped aggregates of an anionic fluoroalkyl sulfonate surfactant (FS) and the supramolecular assembly of these aggregates into a disordered columnar phase (CS). The leeks are formed by wrapping of 2-4 FS-water bilayers of thickness 26-28 Å into 10-20 nm thick and >100 nm long structures, in the concentration regime of 63-70 wt % FS. A lamellar (Lα) lyotropic liquid-crystalline (LLC) phase forms at higher concentration, between 70 and 84 wt %. In the two LLC phases, the FS molecules were organized in an interdigitated or tilted fashion, or a combination of the two. Such a unique supramolecular self-assembly of amphiphiles has not been predicted nor observed before. This self-assembly behavior could be of interest to various fields like microencapsulation, nanomedicine, and membrane protein crystallization.


Subject(s)
Fluorine/chemistry , Microscopy, Electron, Transmission
SELECTION OF CITATIONS
SEARCH DETAIL
...